Cargando…

Health-Related Quality of Life Impacts Mortality but Not Progression to End-Stage Renal Disease in Pre-Dialysis Chronic Kidney Disease: A Prospective Observational Study

BACKGROUND: Chronic kidney disease (CKD) is associated with reduced health-related quality of life (HRQL). However, the relationship between pre-dialysis CKD, HRQL and clinical outcomes, including mortality and progression to end-stage renal disease (ESRD) is unclear. METHODS: All 745 participants r...

Descripción completa

Detalles Bibliográficos
Autores principales: Jesky, Mark D., Dutton, Mary, Dasgupta, Indranil, Yadav, Punit, Ng, Khai Ping, Fenton, Anthony, Kyte, Derek, Ferro, Charles J., Calvert, Melanie, Cockwell, Paul, Stringer, Stephanie J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104414/
https://www.ncbi.nlm.nih.gov/pubmed/27832126
http://dx.doi.org/10.1371/journal.pone.0165675
_version_ 1782466742312763392
author Jesky, Mark D.
Dutton, Mary
Dasgupta, Indranil
Yadav, Punit
Ng, Khai Ping
Fenton, Anthony
Kyte, Derek
Ferro, Charles J.
Calvert, Melanie
Cockwell, Paul
Stringer, Stephanie J.
author_facet Jesky, Mark D.
Dutton, Mary
Dasgupta, Indranil
Yadav, Punit
Ng, Khai Ping
Fenton, Anthony
Kyte, Derek
Ferro, Charles J.
Calvert, Melanie
Cockwell, Paul
Stringer, Stephanie J.
author_sort Jesky, Mark D.
collection PubMed
description BACKGROUND: Chronic kidney disease (CKD) is associated with reduced health-related quality of life (HRQL). However, the relationship between pre-dialysis CKD, HRQL and clinical outcomes, including mortality and progression to end-stage renal disease (ESRD) is unclear. METHODS: All 745 participants recruited into the Renal Impairment In Secondary Care study to end March 2014 were included. Demographic, clinical and laboratory data were collected at baseline including an assessment of HRQL using the Euroqol EQ-5D-3L. Health states were converted into an EQ-5D(index) score using a set of weighted preferences specific to the UK population. Multivariable Cox proportional hazards regression and competing risk analyses were undertaken to evaluate the association of HRQL with progression to ESRD or all-cause mortality. Regression analyses were then performed to identify variables associated with the significant HRQL components. RESULTS: Median eGFR was 25.8 ml/min/1.73 m(2) (IQR 19.6–33.7ml/min) and median ACR was 33 mg/mmol (IQR 6.6–130.3 mg/mmol). Five hundred and fifty five participants (75.7%) reported problems with one or more EQ-5D domains. When adjusted for age, gender, comorbidity, eGFR and ACR, both reported problems with self-care [hazard ratio 2.542, 95% confidence interval 1.222–5.286, p = 0.013] and reduced EQ-5D(index) score [hazard ratio 0.283, 95% confidence interval 0.099–0.810, p = 0.019] were significantly associated with an increase in all-cause mortality. Similar findings were observed for competing risk analyses. Reduced HRQL was not a risk factor for progression to ESRD in multivariable analyses. CONCLUSIONS: Impaired HRQL is common in the pre-dialysis CKD population. Reduced HRQL, as demonstrated by problems with self-care or a lower EQ-5D(index) score, is associated with a higher risk for death but not ESRD. Multiple factors influence these aspects of HRQL but renal function, as measured by eGFR and ACR, are not among them.
format Online
Article
Text
id pubmed-5104414
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-51044142016-12-08 Health-Related Quality of Life Impacts Mortality but Not Progression to End-Stage Renal Disease in Pre-Dialysis Chronic Kidney Disease: A Prospective Observational Study Jesky, Mark D. Dutton, Mary Dasgupta, Indranil Yadav, Punit Ng, Khai Ping Fenton, Anthony Kyte, Derek Ferro, Charles J. Calvert, Melanie Cockwell, Paul Stringer, Stephanie J. PLoS One Research Article BACKGROUND: Chronic kidney disease (CKD) is associated with reduced health-related quality of life (HRQL). However, the relationship between pre-dialysis CKD, HRQL and clinical outcomes, including mortality and progression to end-stage renal disease (ESRD) is unclear. METHODS: All 745 participants recruited into the Renal Impairment In Secondary Care study to end March 2014 were included. Demographic, clinical and laboratory data were collected at baseline including an assessment of HRQL using the Euroqol EQ-5D-3L. Health states were converted into an EQ-5D(index) score using a set of weighted preferences specific to the UK population. Multivariable Cox proportional hazards regression and competing risk analyses were undertaken to evaluate the association of HRQL with progression to ESRD or all-cause mortality. Regression analyses were then performed to identify variables associated with the significant HRQL components. RESULTS: Median eGFR was 25.8 ml/min/1.73 m(2) (IQR 19.6–33.7ml/min) and median ACR was 33 mg/mmol (IQR 6.6–130.3 mg/mmol). Five hundred and fifty five participants (75.7%) reported problems with one or more EQ-5D domains. When adjusted for age, gender, comorbidity, eGFR and ACR, both reported problems with self-care [hazard ratio 2.542, 95% confidence interval 1.222–5.286, p = 0.013] and reduced EQ-5D(index) score [hazard ratio 0.283, 95% confidence interval 0.099–0.810, p = 0.019] were significantly associated with an increase in all-cause mortality. Similar findings were observed for competing risk analyses. Reduced HRQL was not a risk factor for progression to ESRD in multivariable analyses. CONCLUSIONS: Impaired HRQL is common in the pre-dialysis CKD population. Reduced HRQL, as demonstrated by problems with self-care or a lower EQ-5D(index) score, is associated with a higher risk for death but not ESRD. Multiple factors influence these aspects of HRQL but renal function, as measured by eGFR and ACR, are not among them. Public Library of Science 2016-11-10 /pmc/articles/PMC5104414/ /pubmed/27832126 http://dx.doi.org/10.1371/journal.pone.0165675 Text en © 2016 Jesky et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Jesky, Mark D.
Dutton, Mary
Dasgupta, Indranil
Yadav, Punit
Ng, Khai Ping
Fenton, Anthony
Kyte, Derek
Ferro, Charles J.
Calvert, Melanie
Cockwell, Paul
Stringer, Stephanie J.
Health-Related Quality of Life Impacts Mortality but Not Progression to End-Stage Renal Disease in Pre-Dialysis Chronic Kidney Disease: A Prospective Observational Study
title Health-Related Quality of Life Impacts Mortality but Not Progression to End-Stage Renal Disease in Pre-Dialysis Chronic Kidney Disease: A Prospective Observational Study
title_full Health-Related Quality of Life Impacts Mortality but Not Progression to End-Stage Renal Disease in Pre-Dialysis Chronic Kidney Disease: A Prospective Observational Study
title_fullStr Health-Related Quality of Life Impacts Mortality but Not Progression to End-Stage Renal Disease in Pre-Dialysis Chronic Kidney Disease: A Prospective Observational Study
title_full_unstemmed Health-Related Quality of Life Impacts Mortality but Not Progression to End-Stage Renal Disease in Pre-Dialysis Chronic Kidney Disease: A Prospective Observational Study
title_short Health-Related Quality of Life Impacts Mortality but Not Progression to End-Stage Renal Disease in Pre-Dialysis Chronic Kidney Disease: A Prospective Observational Study
title_sort health-related quality of life impacts mortality but not progression to end-stage renal disease in pre-dialysis chronic kidney disease: a prospective observational study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104414/
https://www.ncbi.nlm.nih.gov/pubmed/27832126
http://dx.doi.org/10.1371/journal.pone.0165675
work_keys_str_mv AT jeskymarkd healthrelatedqualityoflifeimpactsmortalitybutnotprogressiontoendstagerenaldiseaseinpredialysischronickidneydiseaseaprospectiveobservationalstudy
AT duttonmary healthrelatedqualityoflifeimpactsmortalitybutnotprogressiontoendstagerenaldiseaseinpredialysischronickidneydiseaseaprospectiveobservationalstudy
AT dasguptaindranil healthrelatedqualityoflifeimpactsmortalitybutnotprogressiontoendstagerenaldiseaseinpredialysischronickidneydiseaseaprospectiveobservationalstudy
AT yadavpunit healthrelatedqualityoflifeimpactsmortalitybutnotprogressiontoendstagerenaldiseaseinpredialysischronickidneydiseaseaprospectiveobservationalstudy
AT ngkhaiping healthrelatedqualityoflifeimpactsmortalitybutnotprogressiontoendstagerenaldiseaseinpredialysischronickidneydiseaseaprospectiveobservationalstudy
AT fentonanthony healthrelatedqualityoflifeimpactsmortalitybutnotprogressiontoendstagerenaldiseaseinpredialysischronickidneydiseaseaprospectiveobservationalstudy
AT kytederek healthrelatedqualityoflifeimpactsmortalitybutnotprogressiontoendstagerenaldiseaseinpredialysischronickidneydiseaseaprospectiveobservationalstudy
AT ferrocharlesj healthrelatedqualityoflifeimpactsmortalitybutnotprogressiontoendstagerenaldiseaseinpredialysischronickidneydiseaseaprospectiveobservationalstudy
AT calvertmelanie healthrelatedqualityoflifeimpactsmortalitybutnotprogressiontoendstagerenaldiseaseinpredialysischronickidneydiseaseaprospectiveobservationalstudy
AT cockwellpaul healthrelatedqualityoflifeimpactsmortalitybutnotprogressiontoendstagerenaldiseaseinpredialysischronickidneydiseaseaprospectiveobservationalstudy
AT stringerstephaniej healthrelatedqualityoflifeimpactsmortalitybutnotprogressiontoendstagerenaldiseaseinpredialysischronickidneydiseaseaprospectiveobservationalstudy